Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
290.19
+3.36 (1.17%)
At close: Oct 2, 2026, 4:00 PM EDT
295.00
+4.81 (1.66%)
After-hours: Oct 2, 2026, 7:30 PM EDT

CRL Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, CRL stock has a consensus rating of "Buy" and an average price target of $305. The average 1-year stock price forecast is 5.10% higher than the current stock price, while the lowest is $145 (-50.03%) and the highest is $357 (+23.02%).

Price Target: $305 (+5.10%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$145$305$322$357
Change-50.03%+5.10%+10.96%+23.02%

Analyst Ratings

The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy1010109910
Buy234344
Hold432322
Sell110000
Strong Sell001111
Total171717161617

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Buy
Initiates
$357
BuyInitiates$357+23.02%Sep 30, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
n/a
BuyReiteratesn/an/aSep 28, 2026
Jefferies
Jefferies
Buy
Maintains
$305 → $340
BuyMaintains$305 → $340+17.16%Sep 28, 2026
Deutsche Bank
Deutsche Bank
Buy
Reiterates
$300 → $320
BuyReiterates$300 → $320+10.27%Sep 25, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$320 → $330
BuyMaintains$320 → $330+13.72%Sep 25, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.92B
from 4.02B
Decreased by -2.42%
Revenue Next Year
4.01B
from 3.92B
Increased by 2.24%
EPS This Year
11.35
from 10.28
Increased by 10.40%
EPS Next Year
12.74
from 11.35
Increased by 12.23%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 25, 2021Dec 31, 2022Dec 30, 2023Dec 28, 2024Dec 27, 2025Dec 31, 2026
Revenue
3.54B3.98B4.13B4.05B4.02B3.92B
Revenue Growth
21.08%12.31%3.86%-1.92%-0.85%-2.42%
Gross Profit
1.34B1.47B1.53B1.41B1.40B1.36B
Gross Margin
37.78%36.91%37.03%34.76%34.98%34.65%
Operating Income
634.39M665.51M648.89M545.86M497.76M821.68M
Net Income
390.98M486.23M474.62M22.20M-144.34M164.12M
EPS
----10.2811.35
EPS Growth
-----0.39%10.40%
Forward PE
33.7219.6622.7418.5319.3225.57
Free Cash Flow
----518.49M318.02M
No. Analysts
-----10
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.0B
Avg3.9B
Low3.9B

Revenue Growth

Revenue Growth202620272028
High
-1.4%
Avg
-2.4%
Low
-2.8%

EPS Forecast

EPS202620272028
High11.49
Avg11.35
Low11.02

EPS Growth

EPS Growth202620272028
High
11.8%
Avg
10.4%
Low
7.2%